Search results

Ok. Again, if the deal closes and Ruiz actually monetizes this, not sure why anything matters insofar as the NewCo is involved.

Why would Ruiz be subject to a clawback?

You are correct. My only point is that this gets monetized for Ruiz if and when the S-1 gets approved (one of the contingencies for closing). He isn't depending on future revenue to get his billions.

If the SPAC deal actually closes, he should be fine. SEC is currently reviewing the S-1. Again, the patent is unbelievable if it can work for large insurance companies - Humana, Blue Cross, etc. - it will save them hundreds of millions by avoiding double payments, overpayments, etc. Long...